{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T07:48:18Z","timestamp":1718524098759},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1038\/ncprheum0098","type":"journal-article","created":{"date-parts":[[2006,5,19]],"date-time":"2006-05-19T16:35:58Z","timestamp":1148056558000},"page":"107-111","source":"Crossref","is-referenced-by-count":1,"title":["Peptic ulcer disease in a patient with ankylosing spondylitis receiving a conventional nonsteroidal anti-inflammatory drug"],"prefix":"10.1038","volume":"2","author":[{"given":"Bernard","family":"Bannwarth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Zerbib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncprheum0098_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.7326\/0003-4819-136-12-200206180-00011","volume":"136","author":"MA Khan","year":"2002","unstructured":"Khan MA (2002) Update on spondyloarthropathies. Ann Intern Med 136: 896\u2013907","journal-title":"Ann Intern Med"},{"issue":"Suppl 3","key":"BFncprheum0098_CR2","doi-asserted-by":"publisher","first-page":"iii8","DOI":"10.1136\/ard.61.suppl_3.iii8","volume":"61","author":"J Sieper","year":"2002","unstructured":"Sieper J  et al. (2002) Ankylosing spondylitis: an overview. Ann Rheum Dis 61 (Suppl 3): iii8\u201318","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0098_CR3","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1056\/NEJM199906173402407","volume":"340","author":"MM Wolfe","year":"1999","unstructured":"Wolfe MM  et al. (1999) Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 340: 1888\u20131899","journal-title":"N Engl J Med"},{"key":"BFncprheum0098_CR4","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1136\/bmj.323.7323.1236","volume":"323","author":"JM Seager","year":"2001","unstructured":"Seager JM and Hawkey CJ (2001) Indigestion and non-steroidal anti-inflammatory drugs. BMJ 323: 1236\u20131239","journal-title":"BMJ"},{"key":"BFncprheum0098_CR5","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/j.1365-2036.2004.01935.x","volume":"19","author":"FKL Chan","year":"2004","unstructured":"Chan FKL and Graham DY (2004) Prevention of non-steroidal anti-inflammatory drug gastrointestinal complications. Review and recommendations based on risk assessment. Aliment Pharmacol Ther 19: 1051\u20131061","journal-title":"Aliment Pharmacol Ther"},{"key":"BFncprheum0098_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1046\/j.1365-2036.2003.01454.x","volume":"17","author":"R Micklewright","year":"2003","unstructured":"Micklewright R  et al. (2003) NSAIDs, gastroprotection and cyclo-oxygenase-II-selective inhibitors. Aliment Pharmacol Ther 17: 321\u2013332","journal-title":"Aliment Pharmacol Ther"},{"key":"BFncprheum0098_CR7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2165\/00002018-200528040-00002","volume":"28","author":"FKL Chan","year":"2005","unstructured":"Chan FKL (2005) NSAID-induced peptic ulcers and Helicobacter pylori infection: implications for patient management. Drug Saf 28: 287\u2013300","journal-title":"Drug Saf"},{"issue":"Suppl 1","key":"BFncprheum0098_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1083-4389.2004.00254.x","volume":"9","author":"A Makristathis","year":"2004","unstructured":"Makristathis A  et al. (2004) Diagnosis of Helicobacter pylori infection. Helicobacter 9 (Suppl 1): 7\u201314","journal-title":"Helicobacter"},{"key":"BFncprheum0098_CR9","first-page":"1175","volume-title":"Helicobacter pylori infection","author":"S Suerbaum","year":"2002","unstructured":"Suerbaum S and Michetti P (2002) Helicobacter pylori infection. N Engl J Med 347: 1175\u20131186"},{"issue":"Suppl 3","key":"BFncprheum0098_CR10","doi-asserted-by":"publisher","first-page":"iii40","DOI":"10.1136\/ard.61.suppl_3.iii40","volume":"61","author":"M Dougados","year":"2002","unstructured":"Dougados M  et al. (2002) Conventional treatments for ankylosing spondylitis. Ann Rheum Dis 61 (Suppl 3): iii40\u201350","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0098_CR11","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1093\/rheumatology\/keh669","volume":"44","author":"A Keat","year":"2005","unstructured":"Keat A  et al. (2005) BSR guidelines for prescribing TNF-\u03b1 blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology. Rheumatology 44: 939\u2013944","journal-title":"Rheumatology"},{"key":"BFncprheum0098_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2165\/00002018-200528030-00001","volume":"28","author":"B Bannwarth","year":"2005","unstructured":"Bannwarth B (2005) Do selective cyclo-oxygenase-2 inhibitors have a future? Drug Saf 28: 183\u2013189","journal-title":"Drug Saf"},{"key":"BFncprheum0098_CR13","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.amjmed.2005.01.001","volume":"118","author":"JD Reveille","year":"2005","unstructured":"Reveille JD and Arnett FC (2005) Spondyloarthritis: update on pathogenesis and management. Am J Med 118: 592\u2013603","journal-title":"Am J Med"},{"key":"BFncprheum0098_CR14","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1136\/ard.62.9.817","volume":"62","author":"J Braun","year":"2003","unstructured":"Braun J  et al. for the ASAS Working Group (2003) International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis 62: 817\u2013824","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0098_CR15","volume-title":"6th Annual European Congress of Rheumatology","author":"J Braun","year":"2005","unstructured":"Braun J  et al. (2005) ASAS\/EULAR recommendations for the management of ankylosing spondylitis. In 6th Annual European Congress of Rheumatology: 2005 June 8\u201311; Vienna"},{"key":"BFncprheum0098_CR16","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/art.20985","volume":"52","author":"D van der Heijde","year":"2005","unstructured":"van der Heijde D  et al. (2005) Evaluation of the efficacy of etoricoxib in ankylosing spondylitis. Results of a fifty-two-week, randomized, controlled study. Arthritis Rheum 52: 1205\u20131215","journal-title":"Arthritis Rheum"}],"container-title":["Nature Clinical Practice Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0098.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0098","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0098.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:57:03Z","timestamp":1684443423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncprheum0098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["BFncprheum0098"],"URL":"https:\/\/doi.org\/10.1038\/ncprheum0098","relation":{},"ISSN":["1745-8382","1745-8390"],"issn-type":[{"value":"1745-8382","type":"print"},{"value":"1745-8390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}